Associate Director, Translational Research
Pyxis Oncology
Dr. Nicolas Severe is the Associate Director in Translational Research of Pyxis Oncology, located in Boston, MA. He leads a team of scientists working on pre-clinical studies for our first-in-concept non-cellular targeting antibody drug conjugate PYX-201, currently being tested in a phase 1 clinical trial in a variety of solid tumors. Nicolas obtained a Ph.D. in Molecular and Cellular Biology from the University Paris-Diderot in France and did his postdoctoral research training at Harvard University and Massachusetts General Hospital.
